Research archive for SYK

Yesterday we received 4th quarter and full year results from one of our recommend healthcare stocks in the US namely Stryker. I've taken a screen grab from the presentation which summarises sales growth amongst the business's divisions. MedSurg is the devices and equipment division, the other 2 are self explanatory.

A couple of days back we received results from one of our recommended healthcare stocks in the US, Stryker. These results were for the 3rd quarter of 2014. This table does many jobs for me. It shows you sales growth, geographic spread and the sales mix between their three main categories, Reconstructive, Medsurg and Neurotechnology and Spine.

Last week we received second quarter results from Stryker. We have written about them before but here is a brief reminder of what this $30bn market cap company does.

Two days ago we received more M&A news in the healthcare sector, this time involving one of Vestact's recommended stocks. Stryker were rumoured to be interested in buying UK company Smith & Nephew. Before we go into the details lets just look at the 2 companies quick.

One of our favourite sectors is the healthcare industry. As global wealth rises so should the amount spent on healthcare, the one thing that can make us live longer and more comfortable. Added to this trend are the ageing baby boomers, who are getting to the age where they require more healthcare.